NASDAQ:BRKR - Bruker Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$37.76 +0.28 (+0.75 %)
(As of 04/26/2019 06:00 AM ET)
Previous Close$37.48
Today's Range$36.84 - $37.91
52-Week Range$26.10 - $40.25
Volume643,131 shs
Average Volume699,816 shs
Market Capitalization$5.92 billion
P/E Ratio26.97
Dividend Yield0.43%
Beta1.47
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.90 billion
Cash Flow$1.8198 per share
Book Value$5.78 per share

Profitability

Net Income$179.70 million

Miscellaneous

Employees6,870
Market Cap$5.92 billion
Next Earnings Date5/2/2019 (Confirmed)
OptionableOptionable

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Friday, February 15th. Investors of record on Tuesday, March 5th will be given a dividend of $0.04 per share on Friday, March 22nd. This represents a $0.16 annualized dividend and a dividend yield of 0.42%. The ex-dividend date is Monday, March 4th. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker declared that its board has authorized a stock repurchase plan on Sunday, June 4th 2017, which permits the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company's leadership believes its shares are undervalued.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) released its quarterly earnings results on Monday, February, 11th. The medical research company reported $0.54 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.54. The medical research company had revenue of $553.60 million for the quarter, compared to analysts' expectations of $544.53 million. Bruker had a return on equity of 26.36% and a net margin of 9.48%. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Bruker.

How can I listen to Bruker's earnings call?

Bruker will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8884372685.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY 2019 earnings guidance on Monday, February, 11th. The company provided earnings per share (EPS) guidance of $1.54-1.58 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.55. The company issued revenue guidance of $2.009-2.028 billion, compared to the consensus revenue estimate of $1.97 billion.

What price target have analysts set for BRKR?

6 analysts have issued 1 year target prices for Bruker's shares. Their predictions range from $30.00 to $50.00. On average, they anticipate Bruker's stock price to reach $38.1667 in the next year. This suggests a possible upside of 1.1% from the stock's current price. View Analyst Price Targets for Bruker.

What is the consensus analysts' recommendation for Bruker?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 2 sell ratings, 1 hold rating, 2 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bruker.

Has Bruker been receiving favorable news coverage?

News coverage about BRKR stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Bruker earned a news sentiment score of -1.5 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next few days.

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include General Electric (GE), Mattel (MAT), Ultra Clean (UCTT), Twitter (TWTR), Clear Channel Outdoor (CCO), US Foods (USFD), American National BankShares (AMNB), General Motors (GM), New York Times (NYT) and Buffalo Wild Wings (BWLD).

Who are Bruker's key executives?

Bruker's management team includes the folowing people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
  • Stacey Desrochers, Treasurer & Director of Investor Relations

Who are Bruker's major shareholders?

Bruker's stock is owned by many different of retail and institutional investors. Top institutional investors include BTIM Corp. (0.39%), Los Angeles Capital Management & Equity Research Inc. (0.36%), CWM LLC (0.18%), BNP Paribas Arbitrage SA (0.14%), Scout Investments Inc. (0.11%) and Meeder Asset Management Inc. (0.02%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker.

Which major investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., Brinker Capital Inc. and First Hawaiian Bank. View Insider Buying and Selling for Bruker.

Which major investors are buying Bruker stock?

BRKR stock was purchased by a variety of institutional investors in the last quarter, including Los Angeles Capital Management & Equity Research Inc., Tibra Equities Europe Ltd, CWM LLC, Calamos Advisors LLC, Meeder Asset Management Inc., Sciencast Management LP, Virtu Financial LLC and BTIM Corp.. View Insider Buying and Selling for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $37.76.

How big of a company is Bruker?

Bruker has a market capitalization of $5.92 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe.

What is Bruker's official website?

The official website for Bruker is http://www.bruker.com.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (NASDAQ BRKR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  551 (Vote Outperform)
Underperform Votes:  601 (Vote Underperform)
Total Votes:  1,152
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel